CYCLINg through transcription: posttranslational modifications of P-TEFb regulate transcription elongation. - Test2 - elhamkhani - TriplyDB

CYCLINg through transcription: posttranslational modifications of P-TEFb regulate transcription elongation.

CYCLINg through transcription: posttranslational modifications of P-TEFb regulate transcription elongation.

http://www.wikidata.org/entity/Q37740906

about

Manipulation of the host protein acetylation network by human immunodeficiency virus type 1 Small-molecule inhibitors of the Myc oncoprotein Identification and Functional Characterisation of CRK12:CYC9, a Novel Cyclin-Dependent Kinase (CDK)-Cyclin Complex in Trypanosoma brucei Protein kinase A regulates molecular chaperone transcription and protein aggregation Mechanisms of HIV Transcriptional Regulation by Drugs of Abuse.Evidence that gene activation and silencing during stem cell differentiation requires a transcriptionally paused intermediate state Acute hypoxia affects P-TEFb through HDAC3 and HEXIM1-dependent mechanism to promote gene-specific transcriptional repression.Involvement of cyclin K posttranscriptional regulation in the formation of Artemia diapause cysts Transcriptional complexity and roles of Fra-1/AP-1 at the uPA/Plau locus in aggressive breast cancer.Snapshots: chromatin control of viral infection.The serine/threonine phosphatase PPM1B (PP2Cβ) selectively modulates PPARγ activity.Visualization of positive transcription elongation factor b (P-TEFb) activation in living cells.Mechanism of glycyrrhizic acid inhibition of Kaposi's sarcoma-associated herpesvirus: disruption of CTCF-cohesin-mediated RNA polymerase II pausing and sister chromatid cohesion.Two-pronged binding with bromodomain-containing protein 4 liberates positive transcription elongation factor b from inactive ribonucleoprotein complexes.Functional interactions between erythroid Krüppel-like factor (EKLF/KLF1) and protein phosphatase PPM1B/PP2Cβ The mTOR Complex Controls HIV Latency.Human immunodeficiency virus (HIV) latency: the major hurdle in HIV eradication Cross-talk among RNA polymerase II kinases modulates C-terminal domain phosphorylation.HIV-1 Tat recruits transcription elongation factors dispersed along a flexible AFF4 scaffold Transcription factor Sp3 represses expression of p21CIP¹ via inhibition of productive elongation by RNA polymerase II.The Bin3 RNA methyltransferase targets 7SK RNA to control transcription and translation Functional interplay between PPM1G and the transcription elongation machinery.The effects of cocaine on HIV transcription Enforcing the pause: transcription factor Sp3 limits productive elongation by RNA polymerase II.SIRT2 directs the replication stress response through CDK9 deacetylation.Transcription elongation control by the 7SK snRNP complex: Releasing the pause.A non-redundant function of cyclin E1 in hematopoietic stem cells.The control of HIV transcription: keeping RNA polymerase II on track RNA polymerase II elongation control.EKLF/KLF1, a tissue-restricted integrator of transcriptional control, chromatin remodeling, and lineage determination.Making a Short Story Long: Regulation of P-TEFb and HIV-1 Transcriptional Elongation in CD4+ T Lymphocytes and Macrophages.Role of Host Factors on the Regulation of Tat-Mediated HIV-1 Transcription.Progesterone receptor induces bcl-x expression through intragenic binding sites favoring RNA polymerase II elongation.Flavopiridol induces phosphorylation of AKT in a human glioblastoma cell line, in contrast to siRNA-mediated silencing of Cdk9: Implications for drug design and development.Positive feedback loop mediated by protein phosphatase 1α mobilization of P-TEFb and basal CDK1 drives androgen receptor in prostate cancer.Phosphatase PPM1A negatively regulates P-TEFb function in resting CD4(+) T cells and inhibits HIV-1 gene expression.Understanding sensitivity to BH3 mimetics: ABT-737 as a case study to foresee the complexities of personalized medicine.Cdk9 T-loop phosphorylation is regulated by the calcium signaling pathway.Identification of Atuveciclib (BAY 1143572), the First Highly Selective, Clinical PTEFb/CDK9 Inhibitor for the Treatment of Cancer.

P2860

Q26795463-2E1F1CEB-4ADA-4EE1-B8A2-93A20EF5BFF6 Q27025648-18F39BC2-1C3C-48CA-AF95-0F16FA870796 Q28534162-BC7B4B7C-FA72-4EC7-856F-FC7B8876F136 Q28571475-5A6EB85C-E9DB-4082-A03D-4864B224FEF3 Q33815611-C17A69C5-8872-4B29-8A9E-B1448AB0D07F Q34008734-5B2BC878-7AB8-4A1F-97C2-511D96854CF3 Q34044359-E691065A-5136-446C-A965-4218A4E6E48E Q34171674-96DD2A0A-C752-44E9-B690-44B8A160A1C6 Q34248908-A3BDA4D1-7184-45F0-85FD-0C6B6D0FA045 Q34315920-8B756F89-979A-4B31-A6B8-3CC917DAE03A Q34322660-F02548E6-0698-4ACA-B514-350A106084F8 Q35121356-8AA97FC5-F793-46DD-9D99-3FC305DF5B59 Q35363036-6A2B0833-D720-469C-98E9-767209538BC3 Q35668935-D19F243F-5543-4504-9F77-097EC59244FA Q35939797-6E8879E1-4FD1-4975-95B5-D83609623808 Q36225471-257D652B-DA5B-4C22-B289-FB762BBDAB72 Q36330062-15DFC7E9-1A7F-4110-9565-A703FF5A8F00 Q36385831-3E6B0210-54A4-4783-9C22-CAB533A03F60 Q36535347-A79D855D-82A9-46BC-8D25-48327D0C3330 Q36759836-425F86DA-743F-44DB-96BB-865A6B42684B Q36776327-F5E37B85-4905-40C1-AB5D-C300CC992F5D Q36794841-E1B7EAF6-7ADB-4AD2-8042-3F2AE585176F Q36906001-854A4ABF-F15C-4C36-8A4C-604486641296 Q37075889-909653E7-5C7B-4831-9509-D3D74C8C19D5 Q37103812-6EC67D3B-4CE3-4F37-9AEB-7AAE46262CF4 Q37194356-D45A605D-120F-4B74-8CDA-137547A3BE4A Q37521401-7670E464-FA59-46B2-A356-7EFC65411644 Q37958430-D59CE7FA-BEB3-4E29-B339-7EE89B7114F0 Q37992154-081A026F-B983-4204-9898-55A5F177E75D Q38054642-B078B919-55C5-41CA-A93E-8406043E2C2F Q38212042-51EF5043-5545-4C84-80CF-237E08681089 Q38430337-23CCEEC2-75D4-49F6-9A42-B4FE0A45AA0B Q39156822-4767BE93-991F-4843-A58C-C93C9770505C Q39385318-AD257199-3E9A-4A10-8834-B89305BCE538 Q42006129-D4B45167-2CF2-4B40-98AC-E3D461C69508 Q42112998-8AA53AC3-B3EB-4EBC-8819-30DA8577DB09 Q42117299-00A7902A-4A30-4C7A-9676-1DE05214E03C Q42847637-B142C6CA-C713-4388-9D53-1BE62F5225EE Q46420204-24D3A2B0-07FC-463B-9716-8250E439D866

P2860

CYCLINg through transcription: posttranslational modifications of P-TEFb regulate transcription elongation.

http://www.wikidata.org/entity/Q37740906

description

article científic

@ca

article scientifique

@fr

articolo scientifico

@it

artigo científico

@pt

bilimsel makale

@tr

scientific article published on 29 May 2010

@en

vedecký článok

@sk

vetenskaplig artikel

@sv

videnskabelig artikel

@da

vědecký článek

@cs

name

CYCLINg through transcription: ...... late transcription elongation.

@en

CYCLINg through transcription: ...... late transcription elongation.

@nl

type

label

CYCLINg through transcription: ...... late transcription elongation.

@en

CYCLINg through transcription: ...... late transcription elongation.

@nl

prefLabel

CYCLINg through transcription: ...... late transcription elongation.

@en

CYCLINg through transcription: ...... late transcription elongation.

@nl

P1433

Q37740906-C8756C76-7F40-44A0-AFFE-1BA2FE0DFC6D

P1476

Q37740906-15EEB4C0-3013-425B-831C-061E1E6724B9

P2093

Q37740906-19E9D038-B1EF-43CB-914A-15879D306454

Q37740906-78ABDCDF-41C1-4F8E-BA47-F4AFB5AEEC49

P2860

Q37740906-00B1306B-D55F-46B3-B05C-6E9BA0CA46A5

Q37740906-01F462EB-8658-4D0F-A5EC-D26F2B9EAEF5

Q37740906-046B01BF-1DB8-41B1-BF5C-4545653E23D7

Q37740906-06126E3E-847D-43AF-8C77-A493AFC8E3E4

Q37740906-0706BC65-760F-4288-9F7B-4C43F9EA7178

Q37740906-081631C1-557C-4315-8602-19525646BFAA

Q37740906-09475B89-81A3-4298-9CB9-EF3B0C67FC35

Q37740906-0C9C4483-B1AC-4BA1-881A-3071730B99D6

Q37740906-1066B72B-2D51-4FE7-892F-937B0BFEBAFB

Q37740906-13F6A856-2833-4A1A-9CA3-B449CA4B8EBA

P304

Q37740906-2D747238-5C38-4EAD-A220-9342D6D7F1C7

P31

Q37740906-AEFF1A94-5779-4E96-8C94-98BA9D71ABA7

P356

Q37740906-BF4E1AAD-181C-430A-840B-FAE85875685D

P433

Q37740906-A494CF92-C2CB-4411-AA36-9954D55E2B5C

P478

Q37740906-20657C47-209F-4F6D-8731-5CB96822D3C4

P50

Q37740906-F4183DDB-94B9-4932-B61E-7CBBD06487B1

P577

Q37740906-3402EEF9-3991-441E-B29E-258A25C20BED

P5875

Q37740906-CDCAB50A-4BDF-4DE2-9C5B-43BDA1766431

P698

Q37740906-98C51060-29B7-427D-AB89-DAC2A3A23E69

P932

Q37740906-639AD073-E109-4111-8931-61B1668DC9F4

P356

P1433

P1476

CYCLINg through transcription: ...... late transcription elongation.

@en

P2093

Sebastian Schroeder

http://www.w3.org/2001/XMLSchema#string

Sungyoo Cho

http://www.w3.org/2001/XMLSchema#string

P2860

Evidence that P-TEFb alleviates the negative effect of DSIF on RNA polymerase II-dependent transcription in vitro

Inhibition of P-TEFb (CDK9/Cyclin T) kinase and RNA polymerase II transcription by the coordinated actions of HEXIM1 and 7SK snRNA

Brd4 recruits P-TEFb to chromosomes at late mitosis to promote G1 gene expression and cell cycle progression

Insights into the function of the human P-TEFb component CDK9 in the regulation of chromatin modifications and co-transcriptional mRNA processing

Acetylation of conserved lysines in the catalytic core of cyclin-dependent kinase 9 inhibits kinase activity and regulates transcription

Structural basis of cyclin-dependent kinase activation by phosphorylation

The bromodomain protein Brd4 is a positive regulatory component of P-TEFb and stimulates RNA polymerase II-dependent transcription

Identification of multiple cyclin subunits of human P-TEFb

Histone crosstalk between H3S10ph and H4K16ac generates a histone code that mediates transcription elongation

Acetylation of cyclin T1 regulates the equilibrium between active and inactive P-TEFb in cells

P304

1697-1705

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.4161/CC.9.9.11346

http://www.w3.org/2001/XMLSchema#string

P433

9

http://www.w3.org/2001/XMLSchema#string

P478

9

http://www.w3.org/2001/XMLSchema#string

P50

P577

2010-05-29T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

43535239

http://www.w3.org/2001/XMLSchema#string

P698

20436276

http://www.w3.org/2001/XMLSchema#string

P932

2956491

http://www.w3.org/2001/XMLSchema#string